Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.
Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K. Isohashi F, et al. Among authors: ogawa k. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):728-34. doi: 10.1016/j.ijrobp.2012.05.021. Epub 2012 Jun 23. Int J Radiat Oncol Biol Phys. 2013. PMID: 22727885
The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix.
Takahashi Y, Koizumi M, Sumida I, Isohashi F, Ogata T, Akino Y, Yoshioka Y, Maruoka S, Inoue S, Konishi K, Ogawa K. Takahashi Y, et al. Among authors: ogawa k. J Radiat Res. 2012 Nov 1;53(6):936-44. doi: 10.1093/jrr/rrs035. Epub 2012 Jul 17. J Radiat Res. 2012. PMID: 22843371 Free PMC article.
Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group.
Yoshioka Y, Suzuki O, Nishimura K, Inoue H, Hara T, Yoshida K, Imai A, Tsujimura A, Nonomura N, Ogawa K. Yoshioka Y, et al. Among authors: ogawa k. J Radiat Res. 2013 Jan;54(1):113-25. doi: 10.1093/jrr/rrs083. Epub 2012 Sep 17. J Radiat Res. 2013. PMID: 22988284 Free PMC article.
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T. Okazawa M, et al. Among authors: ogawa k. Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd. Int J Gynecol Cancer. 2013. PMID: 23385284
Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.
Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y; Japanese Radiation Oncology study Group (JROSG). Isohashi F, et al. Among authors: ogawa k. Radiat Oncol. 2013 Apr 1;8:76. doi: 10.1186/1748-717X-8-76. Radiat Oncol. 2013. PMID: 23547715 Free PMC article.
5,725 results